Finally, DHHC9's broader oncogenic roles, including immune modulation via PD‐L1 or other substrates (e.g., STK3, DYNLL1), were not explored, leaving gaps in understanding its multifaceted contributions to cancer progression. This evidence concerns the gene STK3 and cancer.